MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-02-0014925
Amogen Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹20.33 Lakh
Latest filing
Net loss · FY 2025
₹31.16 Lakh
Net margin -153.3%
EBITDA · FY 2025
₹3.47 Lakh
EBITDA margin 17.1%
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹20 Cr
Issued & subscribed
Open charges
₹75 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
27
Provident fund records
About Amogen Pharma Private Limited
Data last updated:
Amogen Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33110TG2020PTC141754. Its GSTIN is 36AATCA6906B1ZN (Telangana).
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹20 Cr. It is led by directors including Poosapati Venkata Surya Narasimha Raju and Devi Kalyan Kumar Thakasi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 7 & 8 Survey No 3 To 6 Madhapur Durgam Cheruvu Road, Hyderabad, Telangana, India – 500084.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.33 Lakh. For the same year it recorded a net loss of ₹31.16 Lakh (net margin -153.3%) and EBITDA of ₹3.47 Lakh (EBITDA margin 17.1%).
The company has about 27 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹75 Cr on record.
Amogen Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0014925). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amogenpharma.com.
Company Details of Amogen Pharma Private Limited
CIN U33110TG2020PTC141754
Registration Number 141754
Incorporation Date 15 July 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0014925
Key People
Poosapati Venkata Surya Narasimha Raju Director Devi Kalyan Kumar Thakasi Director Akhilesh Raju Poosapati Director Recognitions & Rankings of Amogen Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No 7 & 8 Survey No 3 To 6 Madhapur Durgam Cheruvu Road, Hyderabad, Telangana, India – 500084
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Amogen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Amogen Pharma Private Limited FY 2025 filings available
Amogen Pharma Private Limited reported revenue of ₹20.33 Lakh for FY 2025.
Revenue · FY 2025
₹20.33 Lakh
Net loss · FY 2025
₹31.16 Lakh margin -153.3%
EBITDA · FY 2025
₹3.47 Lakh margin 17.1%
Financial Statement Summary of Amogen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.47 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹31.16 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Amogen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -153.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amogen Pharma are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Amogen Pharma Private Limited
Amogen Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poosapati Venkata Surya Narasimha Raju Also directs: Pardha Infra Private Limited | Director | 15 Jul 2020 | 6 Years 3 Months | Current |
| Devi Kalyan Kumar Thakasi Also directs: Probiome Healthtech Private Limited, Hillsbiofarmm Limited | Director | 21 Nov 2022 | 3 Years 11 Months | Current |
| Akhilesh Raju Poosapati Also directs: Pardha Infra Private Limited | Director | 15 Jul 2020 | 6 Years 3 Months | Current |
Peer Comparison of Amogen Pharma Private Limited
Amogen Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reckon Pharmachem Private Limited | ₹23.01 Lakh (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Analytica Labchem Private Limited | ₹22.25 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Vaaman Laboratories Private Limited | ₹21.72 Lakh (FY 2024) | •••• | •••• | -78.0% | •••• | Hyderabad, Telangana, India |
| Vardhman Life Sciences Private Limited | ₹21.06 Lakh (FY 2015) | •••• | •••• | -66.0% | •••• | New Delhi, Delhi, India |
| Anmol Antioxidants Pvt Ltd | ₹20.76 Lakh (FY 2021) | •••• | •••• | -93.0% | •••• | Ankleshwar, Gujarat, India |
| Amogen Pharma Private Limited this company | ₹20.33 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Tejashrri Intermediates Private Limited | ₹20 Lakh (FY 2019) | •••• | •••• | -96.0% | •••• | Hyderabad, Telangana, India |
| Shriniwas Pharmachem Private Limited | ₹19.42 Lakh (FY 2025) | •••• | •••• | 857.0% | •••• | Narvar, Madhya Pradesh, India |
| Sri Sailama Exim Private Limited | ₹18.45 Lakh (FY 2025) | •••• | •••• | 2273.0% | •••• | Hyderabad, Telangana, India |
| Iner Care (OPC) Private Limited | ₹17.37 Lakh (FY 2024) | •••• | •••• | 4236905.0% | •••• | Vadodara, Gujarat, India |
| Rajbhushan Pharmachem Private Limited | ₹17.03 Lakh (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Amogen Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Amogen Pharma Private Limited
Amogen Pharma Private Limited is audited by V R Gorantla & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V R Gorantla & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Amogen Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Amogen Pharma Private Limited
Open charges
₹75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2023 | Others | ₹75 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Amogen Pharma Private Limited
Employment history and EPFO contributions of people linked to Amogen Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Amogen Pharma Private Limited
Amogen Pharma Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Devi Kalyan Kumar Thakasi ceased to be Additional Director on 28 Sep 2023.
AGM
Amogen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Amogen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Devi Kalyan Kumar Thakasi ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 75.00 Cr with Charge ID 100772865 was registered on 15 Jul 2023.
Appointed
Devi Kalyan Kumar Thakasi was appointed as Director.
Appointed
Akhilesh Raju Poosapati was appointed as Director.
Appointed
Poosapati Venkata Surya Narasimha Raju was appointed as Director.
Incorporation
15 Jul 2020
Amogen Pharma Private Limited was registered on 15 Jul 2020 with Roc Hyderabad & aged 6 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Amogen Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Amogen Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Amogen Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Amogen Pharma Private Limited
Amogen Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AATCA6906B1ZN | Telangana | Active | 17 Aug 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Amogen Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amogen Pharma Private Limited
Amogen Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 July 2020 (6+ years old) and is registered under CIN U33110TG2020PTC141754.
Amogen Pharma reported revenue of ₹20.33 Lakh for FY 2025.
Amogen Pharma has 3 current directors:
- Poosapati Venkata Surya Narasimha Raju - Director
- Devi Kalyan Kumar Thakasi - Director
- Akhilesh Raju Poosapati - Director
Amogen Pharma reported a net loss of ₹31.16 Lakh (net margin -153.3%) and EBITDA of ₹3.47 Lakh (EBITDA margin 17.1%) for FY 2025, as per its filed financial statements.
The GSTIN of Amogen Pharma is 36AATCA6906B1ZN, registered in Telangana.
The CIN (Corporate Identification Number) of Amogen Pharma is U33110TG2020PTC141754. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amogen Pharma was incorporated on 15 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Amogen Pharma by revenue are Reckon Pharmachem Private Limited, Analytica Labchem Private Limited, Vaaman Laboratories Private Limited, Vardhman Life Sciences Private Limited, Anmol Antioxidants Pvt Ltd and 5 more, all in the Pharma industry (API Manufacturers).
Devi Kalyan Kumar Thakasi ceased to be Additional Director on 28 Sep 2023. Devi Kalyan Kumar Thakasi was appointed as Director on 21 Nov 2022. Akhilesh Raju Poosapati was appointed as Director on 15 Jul 2020. Amogen Pharma has 4 board changes on record in total.
Yes, Amogen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0014925).
Amogen Pharma can be reached through the website amogenpharma.com. Its registered office is in Hyderabad, Telangana, India.